RALEIGH, NC / ACCESS Newswire / December 4, 2025 / ACCESS Newswire Inc. (NYSE American:ACCS), an industry-leading communications company, today announced that its Board of Directors has approved an up ...
Structure Therapeutics Inc. (NASDAQ: GPCR), a clinical-stage global biopharmaceutical company developing novel oral small molecule therapeutics for metabolic diseases, with a focus on obesity, today ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback